none title certification

UAB "Cembalta" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

Financial statement report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2022
12,380
6,221
34,293
32,828
16,496
16.72
265.17
209,666
684,365
811
893,220
2023
126,102
126,102
88,018
83,617
83,617
63.36
66.31
293,283
747,100
1
1,040,382
2024
197,850
197,850
152,078
144,474
144,474
75.35
73.02
437,752
299,895
1
737,646
unlock data icon

Register and

explore Okredo data
unlock data icon

Register and

explore Okredo data

2024

Turnover (€)

197,850 €Ascended57 % *

Sales per employee (€)

197,850 €Ascended57 % *

Profit before tax (€)

152,078 €Ascended73 % *

Net Profit (€)

144,474 €Ascended73 % *

Profit per employee (€)

144,474 €Ascended73 % *

Total profitability (%)

75.35 %Ascended18.92 % *

Net profitability (%)

73.02 %Ascended10.12 % *

Equity (€)

437,752 €Ascended49 % *

Amounts Payable And Liabilities (€)

299,895 €Descended-60 % *

Non-current Assets (€)

1 €Ascended0 % *

CurrentAssets (€)

737,646 €Descended-29 % *

*over the last year starting selected period